[EN] MATERIALS AND METHODS FOR THE TREATMENT OF DEPRESSION<br/>[FR] MATERIAUX ET METHODES DE TRAITEMENT DE LA DEPRESSION
申请人:ARYX THERAPEUTICS
公开号:WO2006026251A1
公开(公告)日:2006-03-09
The subject invention provides compounds which are easily metabolized by the metabolic drug detoxification systems. Particularly, fluvoxamine analogs which have been designed to include esters within the structure of the compounds are taught. Also provided are methods of treating depression and affective disorders, such as obsessive compulsive disorder. Pharmaceutical compositions of the fluvoxamine analogs are also taught
Asymmetric Bromolactonization Catalyzed by a C3-Symmetric Chiral Trisimidazoline
A productive alliance: In an enantioselective organocatalytic bromolactonization of 5‐substituted hex‐5‐enoic acids (see scheme), it appears that the formation of an ion pair through interaction of the trisimidazoline catalyst 1 with the substrate both creates a chiral environment and promotes the cyclization by activating the carboxylic acid. DBDMH=1,3‐dibromo‐5,5‐dimethylhydantoin.